Emerging platform bioprocesses for viral vectors and gene therapies

Emerging platform bioprocesses for viral vectors and gene therapies

Bibliographic Details
Main Authors:	Pettitt, D, Smith, J, Fuerstenau-Sharp, M, Bure, K, Holländer, G, Predki, P, Slade, A, Jones, P, Mitrophanous, K, Brindley, D
Format:	Journal article
Published:	BioProcess International 2016

Similar Items

Scalable purification of viral vectors for gene therapy: An appraisal of downstream processing approaches
by: Fuerstenau-Sharp, M, et al.
Published: (2017)

Bioprocessing automation in cell therapy manufacturing: Outcomes of special interest group automation workshop
by: Ball, O, et al.
Published: (2018)

Automation of CAR-T cell adoptive immunotherapy bioprocessing: Technology opportunities to debottleneck manufacturing
by: Bure, K, et al.
Published: (2016)

Cell therapy commercialization: An assessment of translational barriers
by: Pettitt, D, et al.
Published: (2016)

Bioprocess decision support tool for scalable manufacture of extracellular vesicles
by: Ng, K, et al.
Published: (2018)

Viral vectors as vaccine platforms: Deployment in sight
by: Rollier, C, et al.
Published: (2011)

Viral vectors as vaccine platforms: deployment in sight.
by: Rollier, C, et al.
Published: (2011)

Viral vectors as vaccine platforms: from immunogenicity to impact
by: Ewer (nee Russell), K, et al.
Published: (2016)

Bioprocess decision support tool for scalable manufacture of extracellular vesicles
by: Ng, KS, et al.
Published: (2022)

Viral vectors for gene therapy : methods and protocols /
by: Machida, Curtis A.
Published: (2003)

Bioprocess decision support tool for scalable manufacture of extracellular vesicles
by: Ng, Kelvin S., et al.
Published: (2022)

Bioproducts and bioprocesses /
by: Fiecher, A., et al.
Published: (1989)

Gene therapy using viral vector against anxiety
by: Loo, Sze Jie
Published: (2016)

Three dimensional platforms for ex vivo hematopoietic cell bioprocesses
by: Cao, Xue
Published: (2014)

Technique of retinal gene therapy: delivery of viral vector into the subretinal space
by: Xue, K, et al.
Published: (2017)

Viral vector vaccines
by: McCann, N, et al.
Published: (2022)

Viral contamination in biologic manufacture and implications for emerging therapies
by: Barone, Paul, et al.
Published: (2021)

Bioseparation and bioprocessing /
by: Ganapathy, Subramaniam
Published: (1999)

Cellular uptake study of non-viral vectors for gene therapy.
by: Teo, Zi Yong.
Published: (2012)

Rational design of a scalable bioprocess platform for bacterial cellulose production
by: Basu, Anindya, et al.
Published: (2020)

Viral vectors for malaria vaccine development.
by: Li, S, et al.
Published: (2007)

Gene Therapy for Choroideremia Using an Adeno-Associated Viral (AAV) Vector.
by: Barnard, A, et al.
Published: (2014)

Developing combination therapy to improve viral vector cancer vaccine efficacy
by: Noblecourt, L
Published: (2023)

Insufficiency in the reporting of CAR-T manufacturing protocols - a systematic review and mixed-methods analysis
by: Pettitt, D, et al.
Published: (2018)

Microbioreactors for bioprocess development
by: Zhang, Zhiyu (Scientist in chemical engineering) Massachusetts Institute of Technology
Published: (2007)

Ultrafiltration in food and bioprocessing/
by: Cheryan, Munir
Published: ([19-)

Advances in bioprocess engineering /
by: Galindo, Enrique, et al.
Published: (1998)

CAR-T Cells: A systematic review and mixed methods analysis of the clinical trial landscape
by: Pettitt, D, et al.
Published: (2017)

Systems for gene delivery based on combination of viral and non-viral vectors
by: Carlisle, R, et al.
Published: (2000)

Development of sustainable bioprocesses : modeling and assessment /
by: 254855 Heinzle, Elmar, et al.
Published: (2006)

Data reconciliation in bioprocess development
by: Prior, John Joseph
Published: (2005)

Product recovery in bioprocess technology
by: BIOTOL (Project), et al.
Published: (1992)

History and trends in bioprocessing and biotransformation /
by: Scheper, T., et al.
Published: (2002)

Clinical development of viral vectored vaccines against MERS-COV
by: Ewer, K, et al.
Published: (2018)

Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.
by: Pringle, I, et al.
Published: (2009)

High capacity viral vectors for genomic DNA transgene delivery: Applications to gene therapy and functional genomics
by: Wade-Martins, R, et al.
Published: (2004)

Episomal non-viral gene therapy vectors slow progression of atherosclerosis in a model of familial hypercholesterolemia
by: Kerr, A, et al.
Published: (2016)

Viral therapy of cancer /
by: Harrington, Kevin J., 1958-, et al.
Published: (2008)

Systems Engineering for Viral Vector Manufacturing
by: Nguyen, Tam Ngoc Thanh
Published: (2023)

Novel viral vectors in infectious diseases.
by: Humphreys, I, et al.
Published: (2017)